| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Circulation, Vol 51, 421-427, Copyright © 1975 by American Heart Association
DO Williams, EA Amsterdam and DT Mason
Nitroglycerin (NTG) has recently been suggested to decrease myocardial
ischemia and enhance cardiac pump function during acute myocardial
infarction (AMI). To evaluate the sublingual agnet in this condition, the
hemodynamic effects of 0.4 mg NTG administered to 16 supine patients during
the first 72 hours of AMI were determined serially 5, 10 to 15, and 20 to
30 minutes post-NTG. Data were evaluated for the entire group, as well as
for six patients with normal pulmonary artery wedge pressure (PAW) (less
than or equal to 12 mm Hg; mean 7) who formed group I and for ten patients
with elevated PAW (greater than 12 MM Hg; mean 19) who comprised group II.
In the 16 patients, NTG resulted in significant decreases in PAW (14 TO 7
MM Hg; P less than .01), mean systemic arterial pressure (MAP) (95 TO 82 MM
Hg; P less than .01), cardiac index (CI) (1.79 TO 1.46 L/min/m-2; P less
than .02), stroke index (SI) (24 TO 18 CC/M-2; P less than .01) and stroke
work index (SWI) (27 TO 20 GM TIMES M/M-2; P less than .01). These
alterations were significant in both subgroups, with the decline in PAW
greater (P less than .05), while there was no change in group II. There was
no significant change in total peripheral vascular resistance (TPVR) for
the entire group or in the two subgroups. This study demonstrates that,
regardless of initial left ventricular filling pressure, sublingual NTG
given in the acute phase of AMI results in rapid fall in PAW, concomitant
with decreases in systemic blood pressure, cardiac output and SWI, without
changes in TPVR and with little or no effect on heart rate. Since TPVR was
unaltered, the decline in MAP was due to fall in cardiac output. Thus, the
principal action of sublingual NTG in AMI appears to be systemic
venodilation with consequent reduction of ventricular preload. This effect
is translated into decline ofpump output even in patients with high initial
filling pressures. Although NTG may rapidly relieve pulmonary congestion
and lower myocardial oxygen consumption, use of the agent sublingually is
limited in AMI because these salutary effects are accomppanied by
potentially deleterious fall in cardiac output and systemic blood pressure.
ARTICLES
Hemodynamic effects of nitroglycerin in acute myocardial infarction
This article has been cited by other articles:
![]() |
L. Gould, S. Patel, G.I. Gomes, and C.V.R. Reddy Paradoxical Response to the Vasodilators Angiology, February 1, 1982; 33(2): 125 - 130. [PDF] |
||||
![]() |
L. Gould, C.V.R. Reddy, B. Zen, and B.K. Singh Enhancement of Phentolamine by Nitrates in Patients with Congestive Heart Failure Angiology, September 1, 1981; 32(9): 595 - 600. [PDF] |
||||
![]() |
L. Gould, C.V.R. Reddy, Bujung Zen, and B.K. Singh Effect of Nitroglycerin Ointment on Hemodynamics in Patients With Mitral Insufficiency Angiology, October 1, 1980; 31(10): 677 - 685. [Abstract] [PDF] |
||||
![]() |
J. A. Franciosa Outflow Resistance as a Regulator of Left Ventricular Performance Angiology, May 1, 1978; 29(5): 393 - 401. [PDF] |
||||
![]() |
G. S. Francis and A.D. Hagan Nitroglycerin Ointment: a Review Angiology, December 1, 1977; 28(12): 873 - 878. [PDF] |
||||
![]() |
H. H. Wayne Comparison of the Effects of Sustained-Release and Sublingual Nitroglycerine On the Apexcardiogram and Systolic Time Intervals Angiology, March 1, 1977; 28(3): 190 - 202. [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1975 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |